공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 종양 영양학 시장

Oncology Nutrition

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997521
페이지 정보 영문 143 Pages
가격
US $ 4,950 ₩ 5,625,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,875,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 종양 영양학 시장 Oncology Nutrition
발행일 : 2021년 04월 페이지 정보 : 영문 143 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 종양 영양학 시장 규모는 분석기간(2020-2027년)에 7.3%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 15억 달러에서 2027년에는 25억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 두경부는 분석기간 중 7.8%의 CAGR을 나타내고, 8억 2,320만 달러에 달할 전망입니다.

세계의 종양 영양학(Oncology Nutrition) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Abbott Laboratories
  • Danone Nutricia
  • Fresenius Kabi AG

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 암환자 경장 및 비경구 영양 : 서문
    • 종양 영양학 시장 급성장
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
    • 세계적인 암 발생률 상승에 의한 종양 영양학 시장 성장
    • 영양이 불량한 암환자수 증가에 의한 종양 영양학 시장 수요 증가
    • 적절한 영양 관리에 의한 두경부암 환자 임상 결과 개선
    • 종양 영양학 : 제품 상세
    • 영양 보급에 사용되는 시판 조제유
    • 식도암과 영양
    • 두경부암과 영양
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 47개사
LSH 21.04.08

Abstract:

Global Oncology Nutrition Market to Reach $2.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Oncology Nutrition estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027. Head & Neck, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$823.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stomach & Gastrointestinal segment is readjusted to a revised 8.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $455.4 Million, While China is Forecast to Grow at 6.8% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$455.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$440.4 Million by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Pancreatic Segment to Record 7.2% CAGR

In the global Pancreatic segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$141.2 Million in the year 2020 will reach a projected size of US$230.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$290.6 Million by the year 2027.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Danone Nutricia
  • Fresenius Kabi AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Enteral and Parenteral Nutrition in Cancer Patients: A Prelude
    • Oncology Nutrition Market Set for a Rapid Growth
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
    • Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
    • Improved Clinical Outcome for Head and Neck Cancer Patients through Proper Nutrition Management
    • Oncology Nutrition - Product Details
    • Commercial Formulas Used for Feeding
    • Esophageal Cancer and Nutrition
    • Head and Neck Cancer and Nutrition
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Esophageal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Esophageal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Esophageal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 22: USA Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 25: Canada Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Canada Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: Canada 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 28: Japan Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Japan Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: Japan 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 31: China Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: China Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: China 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 34: Europe Current & Future Analysis for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 35: Europe Historic Review for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Europe 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 37: Europe Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 40: France Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: France Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: France 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 43: Germany Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Germany Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Germany 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 46: Italy Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Italy Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Italy 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 49: UK Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: UK Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: UK 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Rest of Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Rest of Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 55: Asia-Pacific Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Asia-Pacific 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 58: Rest of World Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Rest of World Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Rest of World 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Esophageal, Lung and Other Cancer Types for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 47
Back to Top
전화 문의
F A Q